We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
351
Zymeworks
ZYME
$1.75B
– –
-215,000
Closed -$1.32M
STI icon
352
Solidion Technology
STI
$59.7M
– –
-7,353
Closed -$3.69M
BRLS icon
353
Borealis Foods
BRLS
$20M
– –
-238,623
Closed -$2.42M
CERO
354
DELISTED
CERo Therapeutics
CERO
– –
-95
Closed -$1.93M
SOC icon
355
Sable Offshore Corp
SOC
$912M
– –
-143,174
Closed -$1.41M
TVGNW icon
356
Tevogen Inc. Warrant
TVGNW
$812K
– –
-192,665
Closed -$22K
TVGN icon
357
Tevogen Inc. Common Stock
TVGN
$27.3M
– –
-9,545
Closed -$4.85M
ZEO
358
Zeo Energy
ZEO
$19.6M
– –
-477,246
Closed -$4.84M
BNAI
359
Brand Engagement Network
BNAI
$98.2M
– –
-47,570
Closed -$4.71M
GTI
360
DELISTED
Graphjet Technology
GTI
– –
-3,977
Closed -$2.42M
GCTS
361
GCT Semiconductor Holding
GCTS
$221M
– –
-334,072
Closed -$3.35M
FAAS
362
DELISTED
DigiAsia
FAAS
– –
-238,623
Closed -$2.41M
OKLO
363
Oklo
OKLO
$7.89B
– –
-477,246
Closed -$4.66M
SDSTW
364
Stardust Power Inc Warrant
SDSTW
$5.67M
– –
-37,984
Closed -$2K
SDST
365
Stardust Power Inc
SDST
$6.88M
– –
-27,368
Closed -$2.73M
FLD
366
Fold Holdings
FLD
$25.1M
– –
-233,953
Closed -$2.29M
TXNM
367
TXNM Energy Inc
TXNM
$5.93B
– –
-46,872
Closed -$2.14M
BSLK
368
DELISTED
Bolt Projects Holdings
BSLK
– –
-11,539
Closed -$2.27M
BSLKW
369
DELISTED
Bolt Projects Holdings Warrant
BSLKW
– –
-171,364
Closed -$10K
CURR
370
Currenc Group
CURR
$348M
– –
-238,623
Closed -$2.42M
EONR
371
EON Resources
EONR
$24.6M
– –
-229,785
Closed -$2.3M
VEEA
372
Veea Inc
VEEA
$8.57M
– –
-238,623
Closed -$2.37M
EXE
373
Expand Energy Corp
EXE
$21.5B
– –
-15,275
Closed -$1.44M
DEVS
374
DELISTED
DevvStream Corp
DEVS
– –
-38,180
Closed -$3.83M
BZAI
375
Blaize Holdings
BZAI
$148M
– –
-280,744
Closed -$2.81M
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.